Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Theranostics 2020; 10(16):7034-7052. doi:10.7150/thno.47406 This issue Cite

Review

Bioengineering tools to speed up the discovery and preclinical testing of vaccines for SARS-CoV-2 and therapeutic agents for COVID-19

Manuela Teresa Raimondi1✉, Francesca Donnaloja1, Bianca Barzaghini1, Alberto Bocconi1, Claudio Conci1, Valentina Parodi1, Emanuela Jacchetti1*, Stephana Carelli2*

1. Department of Chemistry, Materials and Chemical Engineering G. Natta, Politecnico di Milano, Milano, Italy.
2. Pediatric Clinical Research Center “Fondazione Romeo ed Enrica Invernizzi”, Department of Biomedical and Clinical Sciences L. Sacco, University of Milano, Italy.
*Equally-contributing authors.

✉ Corresponding author: Manuela Teresa Raimondi, Department of Chemistry, Materials and Chemical Engineering “Giulio Natta”, Politecnico di Milano, Milano, Italy; E-mail: manuela.raimondiit.

Citation:
Raimondi MT, Donnaloja F, Barzaghini B, Bocconi A, Conci C, Parodi V, Jacchetti E, Carelli S. Bioengineering tools to speed up the discovery and preclinical testing of vaccines for SARS-CoV-2 and therapeutic agents for COVID-19. Theranostics 2020; 10(16):7034-7052. doi:10.7150/thno.47406. https://www.thno.org/v10p7034.htm
Other styles

File import instruction

Abstract

Graphic abstract

This review provides an update for the international research community on the cell modeling tools that could accelerate the understanding of SARS-CoV-2 infection mechanisms and could thus speed up the development of vaccines and therapeutic agents against COVID-19.

Many bioengineering groups are actively developing frontier tools that are capable of providing realistic three-dimensional (3D) models for biological research, including cell culture scaffolds, microfluidic chambers for the culture of tissue equivalents and organoids, and implantable windows for intravital imaging.

Here, we review the most innovative study models based on these bioengineering tools in the context of virology and vaccinology. To make it easier for scientists working on SARS-CoV-2 to identify and apply specific tools, we discuss how they could accelerate the discovery and preclinical development of antiviral drugs and vaccines, compared to conventional models.

Keywords: Coronavirus, bioengineering, target, antiviral, vaccine, preclinical testing

Citation styles

APA
Raimondi, M.T., Donnaloja, F., Barzaghini, B., Bocconi, A., Conci, C., Parodi, V., Jacchetti, E., Carelli, S. (2020). Bioengineering tools to speed up the discovery and preclinical testing of vaccines for SARS-CoV-2 and therapeutic agents for COVID-19. Theranostics, 10(16), 7034-7052. https://doi.org/10.7150/thno.47406.

ACS
Raimondi, M.T.; Donnaloja, F.; Barzaghini, B.; Bocconi, A.; Conci, C.; Parodi, V.; Jacchetti, E.; Carelli, S. Bioengineering tools to speed up the discovery and preclinical testing of vaccines for SARS-CoV-2 and therapeutic agents for COVID-19. Theranostics 2020, 10 (16), 7034-7052. DOI: 10.7150/thno.47406.

NLM
Raimondi MT, Donnaloja F, Barzaghini B, Bocconi A, Conci C, Parodi V, Jacchetti E, Carelli S. Bioengineering tools to speed up the discovery and preclinical testing of vaccines for SARS-CoV-2 and therapeutic agents for COVID-19. Theranostics 2020; 10(16):7034-7052. doi:10.7150/thno.47406. https://www.thno.org/v10p7034.htm

CSE
Raimondi MT, Donnaloja F, Barzaghini B, Bocconi A, Conci C, Parodi V, Jacchetti E, Carelli S. 2020. Bioengineering tools to speed up the discovery and preclinical testing of vaccines for SARS-CoV-2 and therapeutic agents for COVID-19. Theranostics. 10(16):7034-7052.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use